On day 10 after initiation of chemotherapy, you receive the laboratory results shown in the chart
Which of the laboratory results would you be concerned about, and why?
What will be an ideal response?
The platelets are low and the patient is at risk for bleeding. The serum albumin is low and might
reflect altered nutrition. The ANC is predictably low, and the patient is at high risk for infection;
neutropenic precautions should be observed. The Hgb, Hct, and RBC are normal but should be
monitored because the patient is at risk for anemia related to the chemotherapy.
You might also like to view...
A patient with end-stage heart failure has participated in a family meeting with the interdisciplinary team and opted for hospice care. On what belief should the patient's care in this setting be based?
A) Meaningful living during terminal illness requires technologic interventions. B) Meaningful living during terminal illness is best supported in designated facilities. C) Meaningful living during terminal illness is best supported in the home. D) Meaningful living during terminal illness is best achieved by prolonging physiologic dying.
A team has formed to determine which methods have worked best and which factors influence the implementation of an evidence-based practice program. This is known as ____
a. Authoritarian research b. Autocratic research c. Transformational research d. Translational research
It is recognized that many individuals in the United States do not eat properly; however, it is not always necessary for people to take a vitamin supplement. Who of the following individuals is least likely to need a vitamin supplement?
A) A moderately active adult C) An elderly woman living alone B) A pregnant teenager D) A housewife on a low-calorie diet
A client has been prescribed furosemide (Lasix) for heart failure. What does the nurse know about furosemide (Lasix) in regards to its choice of treatment?
1. It is a first-choice pharmacotherapy. 2. It is a second-choice pharmacotherapy. 3. It is a third-choice pharmacotherapy. 4. It is a fourth-choice pharmacotherapy.